Adagene (ADAG) Fundamentals 2026 — Revenue Analysis | SniperIQ
Adagene (ADAG) is a CN-listed Healthcare company in Biotechnology with a market capitalization of
.58 on the NASDAQ. This SniperIQ fundamentals page covers Adagene's valuation, profitability (net margin -229.5%), revenue ($8M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Adagene's market cap?
Adagene (ADAG) has a market capitalization of approximately
.58 on the NASDAQ. Market cap moves with the live share price.What is Adagene's P/E ratio?
Adagene's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Adagene?
Adagene runs a net profit margin of -229.5%, a gross margin of 92.4%, and an operating margin of -279.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Adagene generate?
Adagene reported revenue of $8M for fiscal year 2025, with net income of -
Does Adagene pay a dividend?
Adagene does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Adagene financially healthy?
Adagene carries a debt-to-equity ratio of 0.18x and a current ratio of 3.07x, with a market beta of 0.58. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Adagene a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Adagene (ADAG) the key facts are: market cap
Track Adagene's full fundamentals live
Get Adagene's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.